Previous Statements by JAZZ
» Jazz Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
» Jazz Pharmaceuticals Inc. Q2 2008 Earnings Call Transcript
» Jazz Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript
Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.
Jim Cramer says the future doesn't look healthy for Fitbit, but he's bullish on Xilinx and T-Mobile.
CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.